跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“Arvidal”
全部
55
临床试验
25
药物
13
机构
7
资讯
10
6个月前
PVP Labs' Taphalgin Receives DEA Non-Controlled Substance Designation, Advancing Non-Addictive Pain Management
去年
Arvinas CEO John Houston Announces Retirement Following PROTAC Breakthrough Success
去年
Arvinas Holding Company Advances in Clinical Trials and Strategic Pipeline Developments
去年
Arvinas Advances Vepdegestrant into Phase 3 Trials for Breast Cancer and Updates Pipeline Milestones
7个月前
Arvinas Appoints Randy Teel as CEO Following First Successful PROTAC Pivotal Trial
去年
Arvinas and Pfizer's Vepdegestrant Plus Abemaciclib Shows Promise in Breast Cancer Trial
9个月前
Arvinas Reports Promising Preclinical Data for ARV-393 and Glofitamab Combination in B-Cell Lymphoma
去年
Arvinas to Present Promising Preclinical Data on PROTAC BCL6 Degrader ARV-393 at AACR 2025
去年
Arvinas' ARV-102 Shows Promising Brain Penetration and LRRK2 Reduction in First-in-Human Parkinson's Trial
5个月前
Orvida Pharma Reports Positive Phase 1a Safety Data for KM-023, First-in-Class TRPV3 Inhibitor for Olmsted Syndrome